Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

S-0509 exhibits potent gastric acid antisecretory effects in animal models

March 31, 1999

Enrollment completed for trial of InKine purgative tablets

March 29, 1999

Lilly and Ribozyme to collaborate on new HCV treatment

March 26, 1999

Hokuriku Seiyaku discusses new agents for constipation at Japanese meeting

March 25, 1999

CCK-A antagonist from Zeria shows promising activity in pancreatitis models

March 25, 1999

Gastrointestinal effects and binding profile of Taisho's 5-HT4 agonist TS-951

March 25, 1999

Positive phase I results reported for Il Yang's proton pump inhibitor

March 23, 1999

Gilead initiates phase III trial of adefovir dipivoxil in treatment of HBV

March 22, 1999

SciClone receives additional Zadaxin marketing approvals in Singapore and Vietnam

March 19, 1999

Benzamides with low nanomolar affinity for 5-HT4 receptors

March 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...